DexCom, Inc.DXCMNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +7.64% | +12.49% | +15.21% | +21.64% | +13.12% |
| Gross Profit Growth | -0.12% | +4.82% | +9.91% | +23.17% | +20.88% |
| EBITDA Growth | -9.75% | +15.51% | +26.20% | +77.17% | +41.68% |
| Operating Income Growth | -12.91% | +32.25% | +34.56% | +59.54% | +70.99% |
| Net Income Growth | -40.81% | -28.01% | +25.30% | +110.85% | +76.20% |
| EPS Growth | -41.79% | -28.95% | +27.78% | +108.57% | +76.92% |
| EPS Diluted Growth | -38.71% | -25.00% | +28.57% | +105.88% | +76.32% |
| Weighted Average Shares Growth | +3.97% | +0.23% | -1.78% | -0.79% | -3.16% |
| Weighted Average Shares Diluted Growth | -2.21% | -2.21% | -2.06% | -0.68% | -1.92% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +125.60% | -12.14% | +8.45% | +230.78% | -2.46% |
| Free Cash Flow Growth | +118.00% | -36.44% | -2.06% | +556.17% | +8.65% |
| Receivables Growth | +4.67% | +18.80% | +37.88% | +13.13% | +24.80% |
| Inventory Growth | -3.04% | -8.64% | +0.07% | +3.04% | +15.94% |
| Asset Growth | +3.51% | +4.16% | +7.76% | +18.04% | -2.23% |
| Book Value per Share Growth | -2.23% | +0.65% | +7.62% | +38.84% | +34.87% |
| Debt Growth | -0.25% | -0.27% | -0.58% | -0.60% | -46.29% |
| R&D Expense Growth | +2.50% | +2.61% | +8.97% | +16.32% | +6.24% |
| SG&A Expenses Growth | +6.02% | -2.88% | -1.41% | +8.16% | -1.80% |